Abstract
Patient engagement (PE) is a well-known strategy introduced and implemented by
pharmaceutical and medical device companies for patient compliance and adherence
to treatment protocols during clinical trials and care processes. This can
affect a wider range of outcomes such as the quality of treatment decisions and
quality of care outcomes. Few studies have paid attention to it. The involvement
of patient is one of the crucial stakeholders of health care in their treatment
that makes controversial opinions about the potential outcomes of their
engagement in various aspects of healthcare. This scoping review was conducted
in 2022 to collect the results of PE. The search was performed in the MEDLINE
and Web of Sciences databases. The selected documents were categorized and
reported by the direct content analysis method. Out of 3974 published documents,
17 articles were selected. Findings are categorized into 4 groups: (1) Health
outcome, (2) patient compliance, (3) self-efficiency, and (4) return on
investment. PE can improve both treatment outcomes and consequently patient
satisfaction and health, as well as the productivity of the service provider.
However, increasing self-care and patient adherence are among the positive
effects of this engagement on the patient, and return on investment is still a
challenge for PE.